MetaCap

Stablecoin Development Corporation (SDEV)

NYSE: SDEVHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.50-0.0574 (-10.30%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SDEV stock chart

Technical analysis

Key statistics

All statistics
Market cap
$36.90M
Ex-dividend date
Sep 30, 2025
52-week range
0.467 – 99.75
Day range
0.467 – 0.5907
Volume / Avg
3.33M / 16.98M
Beta
—

52-week range

$0.467$99.75

SDEV stock today

Shares of Stablecoin Development (SDEV) finished lower on Nov 20 at $0.50, a drop of 10.30% or $0.0574 per share, versus the S&P 500's 3.70% decline. Trading was light, with 3.33M shares changing hands, about 20% of the average daily volume. At this level, SDEV sits near the bottom of its 52-week range of $0.467 to $99.75: 99.5% below the high, set on Jan 9, 2026 and 7.1% above the low.

SDEV is down 98.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 88.4%. Stablecoin Development trades at 0.2x its trailing twelve-month earnings per share of $2.70.

Summary generated from market data by MetaCap's automated system. Methodology

About Stablecoin Development

Company profile

Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Michael John Kazley
Headquarters
EmeryVille, CA
Employees
2

Financial highlights

Full financials

Stablecoin Development reported a net loss of $630.8 million, compared with a loss of $7.2 million a year earlier.

Stablecoin Development annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue—$9.78M$10.46M$14.40M$10.20M
Growth—-6.45%-27.42%+41.16%+2.72%
Net income$-630.78M$-7.22M$-9.64M$-10.61M$-5.82M
EPS (diluted)————$-150.00

Earnings

Earnings history
Last reported (Sep/2026)
Nov 6, 2026
EPS actual vs est.
$0.23 vs —

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$4.00
Ex-dividend date
Sep 30, 2025

SDEV news

All SDEV news

Stablecoin Development peers

Health Care sector
SDEV peer companies
CompanyPrice% ChgMarket capCompare
PLRXPliant Therapeutics Inc.0.5951-4.02%$36.89Mvs SDEV
GRCEGrace Therapeutics Inc.1.71-0.58%$35.97Mvs SDEV
CNTBConnect Biopharma Holdings Limited0.59-6.08%$38.05Mvs SDEV
CUECue Biopharma Inc.4.15-7.78%$34.69Mvs SDEV
DWTXDogwood Therapeutics Inc.1.04-2.36%$39.57Mvs SDEV
VERUVeru Inc.1.94-8.06%$33.08Mvs SDEV
ATNMActinium Pharmaceuticals Inc. (Delaware)1.05-1.87%$33.01Mvs SDEV
TLPHTalphera Inc.0.7852+6.25%$40.80Mvs SDEV

Indexes, lists and sector

Stablecoin Development stock FAQ

What is Stablecoin Development's stock price today?

SDEV last traded at $0.50 as of Nov 20, 4:00 PM EST, down 10.30% on the day. Prices are delayed at least 15 minutes.

Does Stablecoin Development pay a dividend?

Yes. Stablecoin Development pays $0.00 per share annually. The most recent dividend of $4.00 had an ex-dividend date of Sep 30, 2025.

What is SDEV's P/E ratio?

SDEV trades at a trailing P/E ratio of 0.19.

Who is Stablecoin Development's CEO?

Mr. Michael John Kazley is the chief executive officer of Stablecoin Development Corporation, which has about 2 employees.

Has SDEV ever split its stock?

Yes. The most recent SDEV stock split was a 1-for-5 split on Feb 23, 2026, one of 4 splits on record.

What is the SDEV 52-week high?

The 52-week high for SDEV is $99.75 and the 52-week low is $0.467. The stock is currently 99.5% below its high.

Compare SDEV